Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma

doi:10.4254/wjh.v11.i6.542

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6305)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

432

WORD

256

HTML

3001

Figures (1-2)

279

Tables (1-4)

512

Sum=4480

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

742

Download

1083

Sum=1825

Jun 27, 2019 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Jun 27, 2019; 11(6): 542-552
Published online Jun 27, 2019. doi: 10.4254/wjh.v11.i6.542

Open in New Tab Full Size Figure Download Figure

Figure 1 Survival curves of patients with hepatocellular carcinoma. A: Child-Turcotte-Pugh score; B: Barcelona Clinic Liver Cancer (BCLC) staging system; C: TNM staging system; D: Albumin-bilirubin (ALBI) grade; E: Plateltet-ALBI grade; F: ALBI-TNM score; G: ALBI-BCLC score; H: Modified ALB-T score.

Open in New Tab Full Size Figure Download Figure

Figure 2 ROC curves for overall survival of patients with hepatocellular carcinoma according to the studied staging systems.

Citation: Elshaarawy O, Alkhatib A, Elhelbawy M, Gomaa A, Allam N, Alsebaey A, Rewisha E, Waked I. Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma. World J Hepatol 2019; 11(6): 542-552
URL: https://www.wjgnet.com/1948-5182/full/v11/i6/542.htm
DOI: https://dx.doi.org/10.4254/wjh.v11.i6.542